Products

Our products

Learn more about the general medicines, vaccines and specialty medicines we market in India.

Our product areas

Our portfolio spans three product areas: general medicines, vaccines, respiratory and oncology. Globally, we’re prioritising R&D investment in vaccines and specialty medicines, which we expect to grow to around three quarters of our business by 2026.

Business portfolio

Our company's product portfolio comprises a broad range of General Medicines which includes anti-infectives, pain management, vitamins, minerals, nutritionals, hormones, dermatologicals, vaccines for both children and adults, and specialty medicines for respiratory and oncology.

Anti-Infectives

82 Mn

Patients were positively impacted through our anti-infectives portfolio.

Pain Management

104 Mn

Patients relied on Calpol as their preferred choice for managing fever and pain.

Respiratory

60,000

Patients suffering from asthma and COPD positively impacted through our respiratory portfolio.

Dermatologicals

20.3 Mn

Patients treated for their skin conditions through our extensive range of dermatological products